PMID- 32538088 OWN - NLM STAT- MEDLINE DCOM- 20201207 LR - 20210724 IS - 1520-4804 (Electronic) IS - 0022-2623 (Print) IS - 0022-2623 (Linking) VI - 63 IP - 14 DP - 2020 Jul 23 TI - Discovery of Dihydropyrrolo[1,2-a]pyrazin-3(4H)-one-Based Second-Generation GluN2C- and GluN2D-Selective Positive Allosteric Modulators (PAMs) of the N-Methyl-d-Aspartate (NMDA) Receptor. PG - 7569-7600 LID - 10.1021/acs.jmedchem.9b01733 [doi] AB - The N-methyl-d-aspartate receptor (NMDAR) is an ion channel that mediates the slow, Ca(2+)-permeable component of glutamatergic synaptic transmission in the central nervous system (CNS). NMDARs are known to play a significant role in basic neurological functions, and their dysfunction has been implicated in several CNS disorders. Herein, we report the discovery of second-generation GluN2C/D-selective NMDAR-positive allosteric modulators (PAMs) with a dihydropyrrolo[1,2-a]pyrazin-3(4H)-one core. The prototype, R-(+)-EU-1180-453, exhibits log unit improvements in the concentration needed to double receptor response, lipophilic efficiency, and aqueous solubility, and lowers cLogP by one log unit compared to the first-generation prototype CIQ. Additionally, R-(+)-EU-1180-453 was found to increase glutamate potency 2-fold, increase the response to maximally effective concentration of agonist 4-fold, and the racemate is brain-penetrant. These compounds are useful second-generation in vitro tools and a promising step toward in vivo tools for the study of positive modulation of GluN2C- and GluN2D-containing NMDA receptors. FAU - Epplin, Matthew P AU - Epplin MP AUID- ORCID: 0000-0002-1121-3701 AD - Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States. FAU - Mohan, Ayush AU - Mohan A AD - Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States. FAU - Harris, Lynnea D AU - Harris LD AD - Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States. FAU - Zhu, Zongjian AU - Zhu Z AD - Department of Pharmacology and Chemical Biology, Emory University, 1510 Clifton Road, Atlanta, Georgia 30322, United States. FAU - Strong, Katie L AU - Strong KL AD - Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States. FAU - Bacsa, John AU - Bacsa J AUID- ORCID: 0000-0001-5681-4458 AD - Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States. FAU - Le, Phuong AU - Le P AD - Department of Pharmacology and Chemical Biology, Emory University, 1510 Clifton Road, Atlanta, Georgia 30322, United States. FAU - Menaldino, David S AU - Menaldino DS AD - Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States. FAU - Traynelis, Stephen F AU - Traynelis SF AUID- ORCID: 0000-0002-3750-9615 AD - Department of Pharmacology and Chemical Biology, Emory University, 1510 Clifton Road, Atlanta, Georgia 30322, United States. FAU - Liotta, Dennis C AU - Liotta DC AUID- ORCID: 0000-0002-7736-7113 AD - Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States. LA - eng GR - R01 NS065371/NS/NINDS NIH HHS/United States GR - R35 NS111619/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20200706 PL - United States TA - J Med Chem JT - Journal of medicinal chemistry JID - 9716531 RN - 0 (Isoquinolines) RN - 0 (NR2C NMDA receptor) RN - 0 (NR2D NMDA receptor) RN - 0 (Pyrazines) RN - 0 (Pyrroles) RN - 0 (Receptors, N-Methyl-D-Aspartate) SB - IM MH - Allosteric Regulation MH - Animals MH - Drug Design MH - Isoquinolines/chemical synthesis/pharmacology MH - Male MH - Mice, Inbred C57BL MH - Molecular Structure MH - Pyrazines/chemical synthesis/pharmacokinetics/*pharmacology MH - Pyrroles/chemical synthesis/pharmacokinetics/*pharmacology MH - Receptors, N-Methyl-D-Aspartate/*agonists MH - Structure-Activity Relationship MH - Xenopus laevis PMC - PMC7961853 MID - NIHMS1678890 COIS- The authors declare the following competing financial interest(s): SFT is a PI on research grants from Allergan, Biogen, and Janssen to Emory, is a member of the SAB for Sage Therapeutics, the GRIN2B Foundation, CureGRIN Foundation, is a co-founder of NeurOp Inc and AgriThera, and receives licensing fees and royalties for software. DCL is a member of the Board of Directors for NeurOp Inc and co-founder of AgriThera. DCL, DSM, KLS, MPE, SFT are co-inventors on Emory-owned Intellectual Property that includes positive allosteric modulators of NMDA receptor function. EDAT- 2020/06/17 06:00 MHDA- 2020/12/15 06:00 PMCR- 2021/07/23 CRDT- 2020/06/16 06:00 PHST- 2020/06/17 06:00 [pubmed] PHST- 2020/12/15 06:00 [medline] PHST- 2020/06/16 06:00 [entrez] PHST- 2021/07/23 00:00 [pmc-release] AID - 10.1021/acs.jmedchem.9b01733 [doi] PST - ppublish SO - J Med Chem. 2020 Jul 23;63(14):7569-7600. doi: 10.1021/acs.jmedchem.9b01733. Epub 2020 Jul 6.